“…However, in a prospective, right/left comparative open study including 24 patients, treatment of one lesion with topical calcipotriol was compared to one lesion that was left untreated. An average treatment duration of 3.9 months resulted in repigmentation in only three of the [66,67], epidermolytic ichthyosis [68], epidermolytic palmoplantar keratoderma [69], erosive pustular dermatosis of the frontal scalp [70], eruptive vellus hair cysts [71], erythema annulare centrifugum [72], extramammary Paget disease [73], focal acral hyperkeratosis [74], granular parakeratosis [75][76][77], Grover disease [78], hand-foot syndrome [79], hyperkeratosis lenticularis perstans [80], ichthyosis linearis circumflex of Netherto syndrome [81], inflammatory linear verrucous epidermal nevus [82][83][84][85], Kaposi sarcoma [86], keratosis lichenoides chronica [87,88], lichen amyloidosis [89], lichen striatus [90], linear atrophoderma of Moulin [91], morphea or linear scleroderma [92][93][94], nevoid hyperkeratosis [95,96], oral leukoplakia [97,98], peeling skin syndrome [99], pityriasis rubra pilaris [100], progressive symmetrical erythrokeratoderma [101], prurigo nodularis [102], scleroderma [103], Sjogren-Larsson syndrome …”